DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Crystals, molecular complexes, and methods of developing lead compounds for inhibitors of bacterial IMPDH

Abstract

The present invention relates to a data storage medium encoded with the structural coordinates of crystallized molecules and molecular complexes which comprise the active site binding pockets of bacterial IMPDH. Such data storage material is capable of displaying such molecules and molecular complexes, or their structural homologues, as a graphical three-dimensional representation on a computer screen. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen and design compounds, including inhibitory compounds, that bind to IMPDH or homologues thereof. This invention also relates to molecules and molecular complexes that comprise the active site binding pockets of IMPDH or close structural homologues of the active site binding pockets. This invention also relates to compounds and pharmaceutical compositions which are inhibitors of bacterial IMPDH.

Inventors:
; ; ; ;
Issue Date:
Research Org.:
Univ. of Chicago, IL (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1531490
Patent Number(s):
6826488
Application Number:
09/533,466
Assignee:
The University of Chicago (Chicago, IL)
Patent Classifications (CPCs):
C - CHEMISTRY C12 - BIOCHEMISTRY C12Y - ENZYMES
C - CHEMISTRY C12 - BIOCHEMISTRY C12N - MICROORGANISMS OR ENZYMES
DOE Contract Number:  
W-31-109-ENG-38
Resource Type:
Patent
Resource Relation:
Patent File Date: 2000-03-23
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Collart, Frank R., Huberman, Eliezer, Joachimiak, Andrzej, Zhang, Rongguang, and Westbrook, Edwin M. Crystals, molecular complexes, and methods of developing lead compounds for inhibitors of bacterial IMPDH. United States: N. p., 2004. Web.
Collart, Frank R., Huberman, Eliezer, Joachimiak, Andrzej, Zhang, Rongguang, & Westbrook, Edwin M. Crystals, molecular complexes, and methods of developing lead compounds for inhibitors of bacterial IMPDH. United States.
Collart, Frank R., Huberman, Eliezer, Joachimiak, Andrzej, Zhang, Rongguang, and Westbrook, Edwin M. Tue . "Crystals, molecular complexes, and methods of developing lead compounds for inhibitors of bacterial IMPDH". United States. https://www.osti.gov/servlets/purl/1531490.
@article{osti_1531490,
title = {Crystals, molecular complexes, and methods of developing lead compounds for inhibitors of bacterial IMPDH},
author = {Collart, Frank R. and Huberman, Eliezer and Joachimiak, Andrzej and Zhang, Rongguang and Westbrook, Edwin M.},
abstractNote = {The present invention relates to a data storage medium encoded with the structural coordinates of crystallized molecules and molecular complexes which comprise the active site binding pockets of bacterial IMPDH. Such data storage material is capable of displaying such molecules and molecular complexes, or their structural homologues, as a graphical three-dimensional representation on a computer screen. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen and design compounds, including inhibitory compounds, that bind to IMPDH or homologues thereof. This invention also relates to molecules and molecular complexes that comprise the active site binding pockets of IMPDH or close structural homologues of the active site binding pockets. This invention also relates to compounds and pharmaceutical compositions which are inhibitors of bacterial IMPDH.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2004},
month = {11}
}

Works referenced in this record:

Incorporation of Prior Phase Information Strengthens Maximum-Likelihood Structure Refinement
journal, November 1998


Cognitive features of continuous antigenic determinants
journal, February 1988


Recombinant human inosine monophosphate dehydrogenase type I and type II proteins
journal, May 1995


A Controlled Trial of Aerosolized Ribavirin in Infants Receiving Mechanical Ventilation for Severe Respiratory Syncytial Virus Infection
journal, July 1991


Structural Features can be Unconserved in Proteins with Similar Folds
journal, December 1994


Identification of the IMP binding site in the IMP dehydrogenase from Tritrichomonas foetus
journal, October 1995


Cloning and characterization of the gene encoding IMP dehydrogenase from Arabidopsis thaliana
journal, January 1996


Inhibition of IMPDH by Mycophenolic Acid:  Dissection of Forward and Reverse Pathways Using Capillary Electrophoresis
journal, January 1996


[20] Processing of X-ray diffraction data collected in oscillation mode
book, January 1997


Characteristics and Crystal Structure of Bacterial Inosine-5‘-monophosphate Dehydrogenase ,
journal, April 1999


Torsion angle dynamics: Reduced variable conformational sampling enhances crystallographic structure refinement
journal, August 1994


Clinical pharmacokinetic study of tiazofurin administered as a 1-hour infusion
journal, May 1992


Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
journal, September 1998


Crystal Structure of Tritrichomonas foetus Inosine-5‘-monophosphate Dehydrogenase and the Enzyme−Product Complex
journal, September 1997


Expression, Purification, and Characterization of Inosine 5′-Monophosphate Dehydrogenase from Borrelia burgdorferi
journal, August 1997


Trapping of an IMP Dehydrogenase−Substrate Covalent Intermediate by Mycophenolic Acid
journal, January 1996


    Works referencing / citing this record: